David Klonoff
David Klonoff
Medical Director - Diabetes Research Institute, Mills-Peninsula Medical Center, Clin Prof Med, UCSF
Email verificata su diabetestechnology.org - Home page
Citata da
Citata da
Exenatide effects on diabetes, obesity, cardiovascular risk factors and hepatic biomarkers in patients with type 2 diabetes treated for at least 3 years
DC Klonoff, JB Buse, LL Nielsen, X Guan, CL Bowlus, JH Holcombe, ...
Current medical research and opinion 24 (1), 275-286, 2008
Continuous glucose monitoring: roadmap for 21st century diabetes therapy
DC Klonoff
Diabetes care 28 (5), 1231-1239, 2005
Threshold-based insulin-pump interruption for reduction of hypoglycemia
RM Bergenstal, DC Klonoff, SK Garg, BW Bode, M Meredith, RH Slover, ...
New England Journal of Medicine 369 (3), 224-232, 2013
An economic analysis of interventions for diabetes.
DC Klonoff, DM Schwartz
Diabetes care 23 (3), 390-404, 2000
Metabolic effects of two years of exenatide treatment on diabetes, obesity, and hepatic biomarkers in patients with type 2 diabetes: an interim analysis of data from the open…
JB Buse, DC Klonoff, LL Nielsen, X Guan, CL Bowlus, JH Holcombe, ...
Clinical therapeutics 29 (1), 139-153, 2007
Recommendations for standardizing glucose reporting and analysis to optimize clinical decision making in diabetes: the Ambulatory Glucose Profile (AGP)
RM Bergenstal, AJ Ahmann, T Bailey, RW Beck, J Bissen, B Buckingham, ...
Diabetes technology & therapeutics 15 (3), 198-211, 2013
Glycemic characteristics and clinical outcomes of COVID-19 patients hospitalized in the United States
B Bode, V Garrett, J Messler, R McFarland, J Crowe, R Booth, DC Klonoff
Journal of diabetes science and technology 14 (4), 813-821, 2020
Noninvasive blood glucose monitoring
DC Klonoff
Diabetes care 20 (3), 433-437, 1997
Continuous glucose monitoring: an endocrine society clinical practice guideline
DC Klonoff, B Buckingham, JS Christiansen, VM Montori, WV Tamborlane, ...
The Journal of Clinical Endocrinology & Metabolism 96 (10), 2968-2979, 2011
Reagent-less whole-blood glucose meter
BB Sterling, PC Hartstein, KI Li, MD Agostino, DC Klonoff, RD Gaffney, ...
US Patent 6,958,809, 2005
Method and apparatus for improving the accuracy of alternative site analyte concentration measurements
P Rule, J Braig, P Hartstein, H Smith, D Klonoff
US Patent App. 10/302,071, 2003
Insulinomas associated with multiple endocrine neoplasia type I: the need for a different surgical approach
MJ Demeure, DC Klonoff, JH Karam, QY Duh, OH Clark
Surgery 110 (6), 998-1005, 1991
Reduction in duration of hypoglycemia by automatic suspension of insulin delivery: the in-clinic ASPIRE study
S Garg, RL Brazg, TS Bailey, BA Buckingham, RH Slover, DC Klonoff, ...
Diabetes technology & therapeutics 14 (3), 205-209, 2012
The current status of mHealth for diabetes: will it be the next big thing?
DC Klonoff
Journal of diabetes science and technology 7 (3), 749-758, 2013
Continuous glucose monitoring: a review of the technology and clinical use
DC Klonoff, D Ahn, A Drincic
Diabetes Research and Clinical Practice 133, 178-192, 2017
A review of continuous glucose monitoring technology
DC Klonoff
Diabetes Technology & Therapeutics 7 (5), 770-775, 2005
Consensus report: the current role of self-monitoring of blood glucose in non-insulin-treated type 2 diabetes
DC Klonoff, L Blonde, G Cembrowski, AR Chacra, G Charpentier, ...
Journal of diabetes science and technology 5 (6), 1529-1548, 2011
Efficacy of chloroquine and hydroxychloroquine in the treatment of COVID-19
SA Meo, DC Klonoff, J Akram
Eur Rev Med Pharmacol Sci 24 (8), 4539-4547, 2020
Diabetes technology update: use of insulin pumps and continuous glucose monitoring in the hospital
GE Umpierrez, DC Klonoff
Diabetes care 41 (8), 1579-1589, 2018
Macroamylasemia and other immunoglobulin-complexed enzyme disorders
DC Klonoff
Western Journal of Medicine 133 (5), 392, 1980
Il sistema al momento non pu eseguire l'operazione. Riprova pi tardi.
Articoli 1–20